Navigation Links
Stenting Techniques Vie in Branchpoint Lesions
Date:3/29/2008

With drug-eluting stents, is the 'crush' or 'culotte' technique better?

CHICAGO, March 29 /PRNewswire/ -- When stenting is performed for an arterial narrowing at the branchpoint of two coronary arteries -- or a bifurcation lesion -- it can be challenging to achieve full coverage of both vessels without blocking the opening to the side branch. A new study will provide interventional cardiologists with new information on which of two techniques produces the best long-term results when used with a drug-eluting stent.

The Nordic Stent Technique Study will be reported today in a Late-Breaking Clinical Trials session at the SCAI Annual Scientific Sessions in Partnership with ACC i2 Summit (SCAI-ACCi2) in Chicago. SCAI-ACCi2 is a scientific meeting for practicing cardiovascular interventionalists sponsored by the Society for Cardiovascular Angiography and Interventions (SCAI) in partnership with the American College of Cardiology (ACC).

The study, led by Paal Gunnes, MD, Feiring Klinikken, Feiring, Norway, will compare the "culotte" and "crush" techniques. With the culotte technique, two similar stents are threaded into the diseased artery. One is positioned in the main artery and the other in the side branch, so that the two stents overlap in the main artery before the branchpoint. With the crush technique, the side branch stent is positioned so that a small portion protrudes into the main artery. When the stent in the main artery is expanded, it completely covers and crushes the protruding segment of the side-branch stent against the wall of the main artery.

For the study, Dr. Gunnes and his colleagues recruited 425 patients with bifurcation lesions, randomly assigning them to treatment with a drug-eluting stent implanted using either a culotte or crush technique. A total of 345 patients are expected to have had quantitative coronary angiography both at the time of stenting and after eight months of follow-up. The researchers will report
'/>"/>

SOURCE SCAI-ACCi2
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Boston Scientific Carotid Artery Stenting Trials Produce Positive Three-Year Results
2. Addition of INTEGRILIN(R) (Eptifibatide) to Bivalirudin Plus Standard of Care Inhibits Platelet Aggregation in Patients Undergoing Elective Coronary Stenting
3. Boston Scientifics Next-Generation Stent Shows Improved Clinical Outcomes in Complex Lesions

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...RNewswire-FirstCall/--Abaxis,Inc.(Nasdaq: ABAX ),a...oodanalysissystems,announcedtodaythatClintSeverson...21stAnnualPiperJaffrayHealthCareConferenceonWednes...heldattheNewYorkPalaceHotelinNewYorkCity. ,, A...rketsportablebloodanalysissystemsforuseinanyveteri...
(Date:11/25/2009)...wswire/--AccordingtoMillenniumResearchGroup(MRG),t...ence,thenearly$3billionUSmarketfortraumafixationde...arsdespitetherecenteconomicslowdown.MRG,s USMarket...illremainhighlydynamicoverthenextfiveyears,withcom...nderservedsegmentsofthetraumafixationmarket,fuelin...
(Date:11/25/2009)...Newswire/--CempraPharmaceuticalsInc.todayannounced...eofficer,willpresentatthePiperJaffray21stAnnualHea...eNewYorkPalaceHotelinNewYorkCity.Dr.Fernandeswillp...clinicalprogramsforthetreatmentofdrug-resistantpat...cals ,, Foundedin2006,CempraPharmaceuticalsisa...
Breaking Medicine Technology:US Trauma Fixation Device Market Not Seeing Signs of Slowdown 2US Trauma Fixation Device Market Not Seeing Signs of Slowdown 3Hologic to Present at the 2009 Morgan Stanley Global Healthcare Unplugged Conference 56056 1Wounded Warrior Project to Participate in BGC Partners Annual Charity Day 56052 1Wounded Warrior Project to Participate in BGC Partners Annual Charity Day 56052 2Misonix Restructures and Expands Sales Organization in Europe 56049 1Misonix Restructures and Expands Sales Organization in Europe 56049 2Misonix Restructures and Expands Sales Organization in Europe 56049 3Misonix Restructures and Expands Sales Organization in Europe 56049 4
...Sleep Onset and Total,Sleep Time, and key secondar..., were met at both doses - Evotec to host a,confer... , HAMBURG, Germany | OXFORD, England, June 4, 200...unced today positive top-line,results from its fir...with chronic primary insomnia. EVT 201 is a partia...
... cediranib - a selective,VEGF signaling inhibitor ...ession- free at six months(1), CHICAGO, June 04, 2...gent cediranib (AZD2171) were presented today at,t...cal Oncology,(ASCO) from a study in patients with ...brain tumor with a high unmet medical need.,(1) , ...
Other Medicine Technology:Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 2Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 3Evotec AG (DE) - Evotec Reports Positive Proof-of-Concept Top-Line,Results with ... 4Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 2Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 3Investigational Drug Cediranib (AZD2171) Shows Promise in Patients,With Recurrent Glioblastoma (GBM) 4
(Date:11/25/2009)... , Dr. Neil J. Zemmel, a ...launching a new website utilizing the latest inter...cement and breast reconstruction procedures. The n...to create an interactive web experience that&rsquo... virtual tour of Dr. Zemmel’s practice. , ...
(Date:11/25/2009)... , The American Society o...dren’s publishing, education, and media comp...lood,” a dynamic science curriculum designed...dicine, in addition to exposing students to exciti... Washington (PRWEB) November 25, 20...
(Date:11/25/2009)... , BenefitPackages.com, C...Blue Cross, is working to raise awareness during t...iod for seniors that allows them to enroll in a ze...PPO plans from Anthem Blue Cross are available thr...niors. , Calabasas, CA (P...
(Date:11/24/2009)... , A recent study shows that 95 percent of radiat...ch as positron emission tomography (FDG-PET), magn...mputed tomography (4DCT) for target delineation (t...ing cancer), according to an article in the Decemb...f Radiology , ( JACR , www.jacr.org ). , In def...
(Date:11/24/2009)... ,, PHILADELPHIA,Nov.24/PRNewswire-USNewswir...ancisco"Paco"Rodriguezreceivedafatalblowtotheheadd...nnHospital,andafteralleffortstosavehislifewerecond...LifeDonorProgram--thenonprofitorganprocurementorga...wJerseyandDelaware--wascontactedbythehospitalaspar...
Breaking Medicine News(10 mins):Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 2Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 3Health News:Richmond, Virginia Plastic Surgeon Launches State-of-the-Art Breast Surgery Website 4Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:BenefitPackages.com Reveals the Truth About No or Low Cost Medicare Supplement Plan Options Including Anthem Blue Cross Freedom Blue Regional PPO 2Health News:Paying Tribute to Boxer Francisco 'Paco' Rodriguez 2
...althGrades study finds patient outcomes at Houston...best for several service lines, HOUSTON, Oct. 17 ...al Quality in America Study issued today, Houston,...roke, general surgery, and maternity care. Houston...
...er 1,000 HIMs look on as Evelyn Bickley wins CBay,...ccess, sweepstakes, ANNAPOLIS, Md., Oct. 17 CBay...ealthcare BPO services, today announced the winner...i-bin/prnh/20071017/NEW009 ) (Logo: http://www....
...SHINGTON, Oct. 16 Speaker Nancy Pelosi,will hold ...17, at 10:30,a.m. with Bo and Dara Wilkerson and t...la., who was born with a serious heart condition a...tisan SCHIP,bill that covers 10 million children.,...
...ternationally renowned tenor expresses gratitude f...iends of Jose Carreras,International Leukemia Foun...nical research at Fred Hutchinson Cancer Research ...,emeritus director of clinical research at the Hut...
... The breast cancer drugs called taxanes, which inc...increase survival rates when used as part of chemo...t spread, according to a new review of the researc...ents, this study confirms that including taxanes i...
...XTER, Mich., Oct. 16 ReCellular, Inc., the world,...d wireless phones and,accessories, today announced...ed Consumer Cellular ( http://www.consumercellular...s the,country. Proceeds from the new program will ...
Other Medicine News:Health News:Houston Northwest Medical Center's Patient Outcomes Superior 2Health News:Houston Northwest Medical Center's Patient Outcomes Superior 3Health News:CBaySystems Gives Away 2008 Honda Civic at AHIMA 2007 2Health News:Carreras Foundation to Endow Clinical-Research Chair at Fred Hutchinson Cancer Research Center 2Health News:Taxol-type drugs give slight boost to survival rates in early breast cancer 2Health News:Taxol-type drugs give slight boost to survival rates in early breast cancer 3Health News:ReCellular Named Exclusive Cell Phone Recycling Partner for Consumer Cellular 2Health News:ReCellular Named Exclusive Cell Phone Recycling Partner for Consumer Cellular 3
ScanGel® Centrifuge
ScanGel Cards for Blood Typing
ORTHO BIOVUE System Cassette
ScanGel Cards for ABO Reverse Grouping, Antibody Screening and Crossmatching
Medicine Products: